Integrated Filing — IndAS
General information about company
| Scrip Code |
500125 |
| NSE Symbol |
EIDPARRY |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE126A01031 |
| Name of company |
E.I.D-PARRY(INDIA) LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2026 |
| Date of end of financial year |
31-03-2027 |
| Date of board meeting when results were approved |
13-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
30-10-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Second quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
13-11-2026 10:00:00 |
| End date and time of board meeting |
13-11-2026 14:40:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
11,21,333.17 |
20,16,587.82 |
|
Other income |
887.72 |
3,488.98 |
|
Total income |
11,22,220.89 |
20,20,076.80 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
6,23,567.88 |
11,11,178.00 |
| (b) |
Purchases of stock-in-trade |
2,21,601.00 |
4,89,596.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
39,676.80 |
(33,813.90) |
| (d) |
Employee benefit expense |
36,584.00 |
73,894.00 |
| (e) |
Finance costs |
14,364.80 |
25,569.70 |
| (f) |
Depreciation, depletion and amortisation expense
|
19,257.00 |
43,562.00 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
1,01,282.60 |
2,02,037.30 |
|
Total other expenses |
1,01,282.60 |
2,02,037.30 |
|
Total expenses |
10,56,334.08 |
19,12,023.10 |
| 3 |
Total profit before exceptional items and tax |
65,886.81 |
1,08,053.70 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
65,886.81 |
1,08,053.70 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
19,091.26 |
30,150.87 |
| 8 |
Deferred tax |
(1,293.82) |
(1,218.19) |
| 9 |
Total tax expenses |
17,797.44 |
28,932.68 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
48,089.37 |
79,121.02 |
| 12 |
Profit (loss) from discontinued operations before tax |
(146.03) |
(27.64) |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
(146.03) |
(27.64) |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
0.00 |
0.00 |
| 16 |
Total profit (loss) for period |
47,943.34 |
79,093.38 |
| 17 |
Other comprehensive income net of taxes |
(1,051.37) |
(1,936.00) |
| 18 |
Total Comprehensive Income for the period |
46,891.97 |
77,157.38 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
25,286.027 |
39,446.24 |
|
Total profit or loss, attributable to non-controlling interests |
22,656.981 |
39,647.006 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
23,906.179 |
37,714.392 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
22,986.006 |
39,442.854 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
1,780.00 |
1,780.00 |
|
Face value of equity share capital |
1 |
1 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
14.29 |
22.18 |
|
Diluted earnings (loss) per share from continuing operations |
14.27 |
22.15 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
-0.09 |
-0.02 |
|
Diluted earnings (loss) per share from discontinued operations |
-0.09 |
-0.02 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
14.2 |
22.16 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
14.18 |
22.13 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2026 |
| Date of end of reporting period |
30-09-2026 |
| Whether results are audited or unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
5,73,915.20 |
|
Capital work-in-progress |
65,242.90 |
|
Investment property |
6,841.00 |
|
Goodwill |
61,749.00 |
|
Other intangible assets |
1,03,835.30 |
|
Intangible assets under development |
5,186.00 |
|
Biological assets other than bearer plants |
|
|
Investments accounted for using equity method |
|
|
Non-current financial assets |
|
|
Non-current investments |
42,755.68 |
|
Trade receivables, non-current |
|
|
Loans, non-current |
31,319.00 |
|
Other non-current financial assets |
|
| 1 |
Other financial assets |
1,307.38 |
|
Total of other non-current financial assets |
1,307.38 |
|
Total non-current financial assets |
75,382.06 |
|
Deferred tax assets (net) |
3,573.00 |
|
Other non-current assets |
|
| 1 |
Right-of-use assets |
77,419.29 |
| 2 |
Income tax assets (net) |
3,113.00 |
| 3 |
Other non-current assets |
22,067.00 |
|
Total of other non-current assets |
1,02,599.29 |
|
Total non-current assets |
9,98,323.75 |
| 2 |
Current assets |
|
|
Inventories |
9,44,248.13 |
|
Current financial asset |
|
|
Current investments |
1,70,417.00 |
|
Trade receivables, current |
3,02,239.40 |
|
Cash and cash equivalents |
53,703.50 |
|
Bank balance other than cash and cash equivalents |
7,762.00 |
|
Loans, current |
87,249.00 |
|
Other current financial assets |
|
|
Total of other current financial assets |
3,60,045.23 |
|
Total current financial assets |
9,81,416.13 |
|
Current tax assets (net) |
957.87 |
|
Other current assets |
|
| 1 |
Other current assets |
1,72,827.80 |
|
Total of other current assets |
1,72,827.80 |
|
Total current assets |
20,99,449.93 |
| 3 |
Non-current assets classified as held for sale |
1,258.50 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
|
|
Total assets |
30,99,032.18 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
1,780.00 |
|
Other equity |
9,13,051.82 |
|
Total equity attributable to owners of parent |
9,14,831.82 |
|
Non controlling interest |
6,55,799.00 |
|
Total equity |
15,70,630.82 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
7,795.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
|
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
|
|
Total Trade payable |
|
|
Other non-current financial liabilities |
|
| 1 |
Lease liability |
69,314.34 |
| 2 |
Other financial liabilities |
892.00 |
|
Total of other non-current financial liabilities |
70,206.34 |
|
Total non-current financial liabilities |
78,001.34 |
|
Provisions, non-current |
7,859.00 |
|
Deferred tax liabilities (net) |
24,124.41 |
|
Deferred government grants, Non-current |
|
|
Other non-current liabilities |
|
|
Total of other non-current liabilities |
|
|
Total non-current liabilities |
1,09,984.75 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
1,64,842.86 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
14,207.51 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
3,51,155.10 |
|
Total Trade payable |
3,65,362.61 |
|
Other current financial liabilities |
|
| 1 |
Lease liability |
4,585.95 |
| 2 |
Acceptances |
7,85,219.00 |
| 3 |
Other financial liabilities |
51,959.25 |
|
Total of other current financial liabilities |
8,41,764.20 |
|
Total current financial liabilities |
13,71,969.67 |
|
Other current liabilities |
46,446.94 |
| 1 |
Other current liabilities |
28,713.94 |
| 2 |
Short term provisions |
17,517.00 |
| 3 |
Current tax liability |
216.00 |
|
Total of other current liabilities |
46,446.94 |
|
Provisions, current |
0.00 |
|
Current tax liabilities (Net) |
|
|
Deferred government grants, Current |
|
|
Total current liabilities |
14,18,416.61 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
|
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
|
|
Total liabilities |
15,28,401.36 |
|
Total equity and liabilites |
30,99,032.18 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| Date of end of reporting
period |
30-09-2026 |
30-09-2026 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Nutrient and allied business |
9,04,218.20 |
15,99,321.00 |
| 2 |
Crop protection. |
1,30,847.71 |
2,55,924.00 |
| 3 |
Sugar |
48,639.00 |
89,617.00 |
| 4 |
Co-generation |
1,767.00 |
2,433.00 |
| 5 |
Distillery |
30,504.00 |
55,986.00 |
| 6 |
Nutraceuticals |
7,010.00 |
13,118.00 |
| 7 |
Consumer products |
12,044.00 |
21,464.00 |
| 8 |
Revenue from Discontinued operations |
0.0063709 |
7,134.09 |
|
Total Segment Revenue |
11,35,667.00 |
20,44,997.09 |
|
Less: Inter segment revenue |
13,696.84 |
21,275.27 |
|
Revenue from operations |
11,21,970.16 |
20,23,721.82 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Nutrient and allied business |
74,589.60 |
1,22,481.00 |
| 2 |
Crop protection. |
13,033.40 |
30,048.00 |
| 3 |
Sugar |
533.31 |
(4,335.69) |
| 4 |
Co-generation |
(2,984.60) |
(5,177.89) |
| 5 |
Distillery |
216.80 |
1,083.20 |
| 6 |
Nutraceuticals |
766.95 |
755.58 |
| 7 |
Consumer products |
(2,448.00) |
(3,646.00) |
| 8 |
Revenue from Discontinued operations |
(146.03) |
(27.64) |
|
Total Profit before tax |
83,561.43 |
1,41,180.56 |
|
i. Finance cost |
14,365.10 |
25,570.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
3,456.00 |
7,584.00 |
|
Profit before tax |
65,740.33 |
1,08,026.56 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Nutrient and allied business |
19,40,962.00 |
19,40,962.00 |
| 2 |
Crop protection. |
4,96,202.00 |
4,96,202.00 |
| 3 |
Sugar |
1,06,656.11 |
1,06,656.11 |
| 4 |
Co-generation |
15,565.41 |
15,565.41 |
| 5 |
Distillery |
63,145.33 |
63,145.33 |
| 6 |
Nutraceuticals |
32,127.83 |
32,127.83 |
| 7 |
Consumer products |
10,416.83 |
10,416.83 |
| 8 |
Revenue from Discontinued operations |
9,692.27 |
9,692.27 |
|
Total Segment Asset |
26,74,767.78 |
26,74,767.78 |
|
Un-allocable Assets |
4,24,264.40 |
4,24,264.40 |
|
Net Segment Asset |
30,99,032.18 |
30,99,032.18 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Nutrient and allied business |
11,44,943.00 |
11,44,943.00 |
| 2 |
Crop protection. |
1,18,258.00 |
1,18,258.00 |
| 3 |
Sugar |
28,969.08 |
28,969.08 |
| 4 |
Co-generation |
1,854.46 |
1,854.46 |
| 5 |
Distillery |
4,970.82 |
4,970.82 |
| 6 |
Nutraceuticals |
12,653.39 |
12,653.39 |
| 7 |
Consumer products |
4,785.81 |
4,785.81 |
| 8 |
Revenue from Discontinued operations |
3,293.70 |
3,293.70 |
|
Total Segment Liabilities |
13,19,728.26 |
13,19,728.26 |
|
Un-allocable Liabilities |
2,08,673.10 |
2,08,673.10 |
|
Net Segment Liabilities |
15,28,401.36 |
15,28,401.36 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Remeasurement of defined benefit plans |
(381.00) |
(435.00) |
| 2 |
Equity instruments through other comprehensive income |
(1,560.57) |
(1,504.00) |
|
Total Amount of items that will not be reclassified to profit and loss |
(1,941.57) |
(1,939.00) |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
(319.00) |
(325.00) |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Exchange differences on translation of foreign operations |
(4.45) |
733.00 |
| 2 |
Fair value movement of cashflow hedge instrument |
769.65 |
(1,303.00) |
|
Total Amount of items that will be reclassified to profit and loss |
765.20 |
(570.00) |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
194.00 |
(248.00) |
| 5 |
Total Other comprehensive income |
(1,051.37) |
(1,936.00) |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
1,08,053.70 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
25,883.00 |
|
Adjustments for decrease (increase) in inventories |
(77,792.00) |
|
Adjustments for decrease (increase) in trade receivables, current |
(65,287.00) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
(1,36,727.00) |
|
Adjustments for decrease (increase) in other current assets |
(27,839.00) |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
0.00 |
|
Adjustments for other financial assets, current |
26,222.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
(83,562.00) |
|
Adjustments for increase (decrease) in trade payables, non-current |
2,83,009.00 |
|
Adjustments for increase (decrease) in other current liabilities |
(1,754.00) |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
43,562.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
331.32 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
(6,220.00) |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
6,120.00 |
|
Adjustments for dividend income |
293.00 |
|
Adjustments for interest income |
6,200.00 |
|
Adjustments for share-based payments |
347.00 |
|
Adjustments for fair value losses (gains) |
(2,452.00) |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
(2,409.00) |
|
Other adjustments to reconcile profit (loss) |
(28.00) |
|
Other adjustments for non-cash items |
(32.00) |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
(25,120.68) |
|
Net cash flows from (used in)
operations |
82,933.02 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
24,440.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
58,493.02 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
37,238.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
0.00 |
|
Purchase of property, plant and equipment |
68,494.00 |
|
Proceeds from sales of investment property |
1,009.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
293.00 |
|
Interest received |
4,186.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
41,400.22 |
|
Net cash flows from (used in)
investing activities |
15,632.22 |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
1,229.00 |
|
Proceeds from issuing other equity instruments |
28.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
1,448.00 |
|
Repayments of borrowings |
3,95,629.00 |
|
Payments of lease liabilities |
8,920.00 |
|
Dividends paid |
2,609.00 |
|
Interest paid |
21,563.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
2,83,418.00 |
|
Net cash flows from (used in)
financing activities |
(1,42,598.00) |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
(68,472.76) |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
17.00 |
|
Net increase (decrease) in cash
and cash equivalents |
(68,455.76) |
|
Cash and cash equivalents cash flow statement at beginning of period
|
1,22,160.00 |
|
Cash and cash equivalents cash
flow statement at end of period |
53,704.24 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Unaudited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
Price Waterhouse chartered accountants LLP |
Yes |
30-11-2026 |